An acute coronary occlusion causes severe myocardial ischemia, which might progress to necrosis and scar tissue formation. Thrombolytic therapy, spontaneous reperfusion, or collateral blood flow can modify the evolution of an acute myocardial infarction and may salvage ischemically injured myocardium.1-3 Restoration of coronary blood flow may therefore lead to an improvement in segmental contractile function in some patients but prove ineffective in those with completed injury. 4 Potentially salvageable myocardium can be identified with positron emission tomography (PET) and be distinguished from myocardium with a completed infarction.5-7 An earlier study performed with PET demonstrated qualitatively that glucose metabolic activity as evidence of persistent ischemia was preserved in nearly half of recent clinical infarct regions.8 More advanced PET instrumentation and biochemically validated tracer kinetic models now permit the noninvasive quantification of regional myocardial blood flow, oxidative metabolism, and glucose utilization. It was therefore the purpose of this study to characterize quantitatively the relations between regional myocardial blood flow and oxidative and glucose metabolism in patients with recent myocardial infarction and to examine whether such quantitative measurements would provide additional insights into the pathophysiology of recent myocardial injury in humans.
Methods

Patient Population
The study population consisted of 22 patients (age, 63±9 years) with a recent myocardial infarction documented by enzymatic and/or ECG criteria. A left bundle branch block precluded ECG infarct localization in 2 patients. Eight patients underwent coronary thrombolysis within 4 hours. Direct angioplasty was per-formed in 2 patients within 8 hours of the onset of chest pain. There were 14 Q-wave and 6 non-Q-wave infarctions. Creatine phosphokinase (CPK) and CKMB serum levels averaged 1357±865 and 74±66 U/L, respec- tively (range, 190 to 3000 and 21 to 274 U/L). Additional demographic information is given in Table 1. PET was performed at 86±38 hours (range, 21 to 170 hours) after the onset of chest pain, when patients were clinically stable. Sixteen patients were studied with
[l3N]ammonia, [11C] acetate, and '8F-deoxyglucose, and 6 patients were examined only with [13N]ammonia and 18F-deoxyglucose. Twenty of the 22 patients underwent coronary angiography (Table 1) . PET was performed before angiography in 3 patients and after angiography in 17 patients. All patients were on oral or intravenous nitroglycerin, and 4 were heparinized at the time of the PET study. Each patient signed an informed consent form approved by the UCLA Human Subject Protection Committee.
Coronary Angiography
Coronary angiography was performed in 20 of the 22 patients within 2.8±1.8 days of the PET study. Contrast left ventriculograms were obtained in all but 1 patient with markedly elevated left ventricular end-diastolic pressure (Table 1 ). In this (patient 10) and the 2 other patients without cardiac catheterization (Table 1 , patients 7 and 18), the left ventricular ejection fraction was determined by two-dimensional echocardiography. The infarct vessel status was determined qualitatively according to the TIMI criteria (TIMI grade 0 or I, occlusion; TIMI grade II or III, patency). 4 
Two-dimensional Echocardiography
Regional wall motion was evaluated with two-dimensional echocardiography on the day of the PET study using four-and two-chamber and apical long-axis views. On each view, the myocardium was divided into six equal segments. Wall motion in each segment was graded by one observer (J.K.), who was unaware of the clinical and PET findings. Grading was on a four-point scale in which normal is 3, mild hypokinesis is 2, severe hypokinesis is 1, and akinesis/dyskinesis is 0. To facilitate the comparison between the PET and echocardiographic studies, a wall motion score was derived by dividing the sum of all echocardiographic scores for each of the seven anatomic segments (anteroseptal, anterior, lateral, posterolateral, inferior, apical, and posteroseptal) by the number of projections on which the segment was visualized. The Only the myocardial 13N activity curves were corrected for spillover of activity from the blood pool to the myocardium. Correction for spillover was performed by treating spillover as an additional parameter in the curve-fitting procedure in addition to the model parameters as previously described.'5 Regions with excessively high spillover fractions (ie, the ratio of blood pool contamination to total tissue activity >80%) were excluded from analysis to avoid a marked underestimation of tissue tracer concentrations and hence, blood flows in these segments. ' To obtain the best fit for the relation between blood flow and oxidative metabolism, the optimum threshold between the low and the high flow range was determined by repeatedly fitting two regression lines simultaneously to the data by least-squares regression analysis. 25 As a second step, the F test was used to test whether this relation was better described by a piecewise linear or a linear fit. In this case, the F test is a special likelihood ratio test for nested models. 25 Probability values of P<.05 were considered to be statistically significant.
Results
Coronary Anatomy
Single-vessel disease was present in 10 patients, twovessel disease in 7, and three-vessel disease in 3 ( Table  1 ). The extensive blood flow-metabolism mismatch in the anterior septum, the anterior wall, the apex, and the inferior septum.
Regional Myocardial Wall Motion
The location of the hypoperfused segments corresponded to the ECG site of the infarct as well as to the site of regional wall motion abnormalities ( Ins (IU/L) 57±50 
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HR, heart rate; bpm, beats per minute; BP, systolic blood pressure; RPP, rate-pressure product; Glc I, II, III, IV, plasma glucose levels at the beginning and at the last three frames of the glucose metabolic study; FFA, mean plasma free fatty acid levels; Ins, mean plasma insulin levels.
was mildly hypokinetic in the territory of the infarct vessel in the other patient (patient 11). The severity of regional wall motion abnormalities in clinical infarct regions ranged from mild hypokinesis to akinesis ( Table  1 ). The wall motion score averaged 1.0±0.6 in segments with PET mismatches and 0.9±0.3 in segments with PET matches (P=NS). There was no statistically significant correlation between the severity of segmental flow reductions and the segmental wall motion score.
Metabolic and Hemodynamic Findings
Average heart rates, blood pressure, and the ratepressure product are given in Table 2 . As further indicated in Table 2 , glucose levels remained relatively constant throughout the 18F-deoxyglucose study.
Myocardial 
Relation Between Blood Flow and Metabolism
As demonstrated in Fig 5, no correlation existed between absolute rates of exogenous glucose utilization and absolute myocardial blood flow. This was because glucose metabolic rates in normal and hypoperfused myocardium varied considerably between patients and correlated with neither cardiac work nor plasma glucose, free fatty acid, or insulin levels. Glucose metabolic rates in PET mismatch and PET match segments were therefore normalized in each patient to those in normal myocardium (Fig 5) . The normalized metabolic rates (in percentage of those in normal myocardium) were then compared with normalized blood flows (again in percentage of those in normal myocardium). As depicted in Fig 5B , normalized glucose metabolic rates declined in PET match segments in proportion to normalized blood flows. By definition and as expected, in PET mismatch segments they exceeded the relative blood flows and, on average, did not decline with blood flow. Interestingly, the normalized glucose metabolic rates for PET match segments occupied the lower and those for PET mismatch segments the upper end of the spectrum of flow reductions, although there was considerable overlap. For example, of the 20 segments with relative flow reductions of 250%, 15 (or 75%) had PET matches and only 25% PET mismatches. Conversely, there was considerable overlap between PET matches and mismatches for flow reductions from 30% to 50% (Fig SB) .
In contrast, segmental rates of oxidative metabolism correlated significantly with segmental blood flows. As illustrated in Fig 6 , lower blood flows in normal myocardium and moderate reductions in hypoperfused myocardium were associated with disproportionately smaller decrements in oxidative metabolism. When blood flow fell below values of about 0.5 mL* g1 nmin', oxidative metabolism declined more steeply. The data plots therefore demonstrated a piecewise relation between flow and oxygen consumption. To obtain the best fit for this data set, the optimum threshold between the low and the high flow range was determined by repeatedly fitting two regression lines simultaneously to the data by least-squares regression analysis. 25 The best discriminator between the two pieces of the curve was found to be at a flow of 0.56 mL.*g`. min1. As a second step, the F test was used to prove that the piecewise linear fit described the data better than a single linear fit (F=4.54>F=3.11; P<.05).
Because of the relatively wide range of blood flows in normal myocardium, largely as a function of interpatient differences in the rate-pressure products as shown in Fig 4 , blood flows and rates of oxidative metabolism in PET mismatch and PET match segments were normalized to those in normal myocardium. The normalized blood flows are plotted against the normalized rates of oxidative metabolism in Fig 7. It is of interest that the slope between blood flow and oxidative metabolism was less steep for PET mismatch than that for PET match segments (P<.05). Of further note is that normalized oxidative metabolism was a relatively accurate discriminator between ischemic and infarcted tissue. Of 21 segments with >30% reductions of oxidative metabolism, 17 (or 80%) were classified as PET match and only 4 as PET mismatch. In contrast, 13 of 14 segments (93%) with reductions of <25% were classified as PET mismatch. Rates of glucose utilization relative to overall oxidative metabolism can be estimated from the ratio of k mono (expressed as percentage of that in normal myocardium) to normalized rates of glucose metabolism (as percentage of those in normal myocardium). This index was 1.0±0.13 in normal myocardium but increased to 1.30±0.46 in mismatch segments (P<.05). In contrast, it was reduced to 0.72±0.33 in segments with matched defects (P<.05 vs normal and mismatch). Discussion To the best of our knowledge, this is the first study that has quantified segmental blood flow together with rates of oxidative metabolism and glucose utilization rates in patients after a recent myocardial infarction. Blood flow and oxidative metabolism were more severely reduced in PET chest pain to the PET studies. This was dictated largely by the patient's clinical condition and thus the safety for transport to the imaging laboratory. Whereas some patients were studied as early as 21 hours after the onset of chest pain, others could not be examined until 1 week later. Therefore, disparities between blood flow and oxidative metabolism that possibly existed early after the acute event26 may have resolved by the time of the study. For example, both patients without flow defects were studied more than 72 hours after the acute event. Had they been examined earlier, blood flow or metabolic abnormalities might have been found. However, the variable timing of the PET studies after the acute event did not appear to affect the observed relations between blood flow, oxidative metabolism, and rates of glucose utilization. Separate analysis of these findings in patients studied within 3 days (n=9) and in those >3 days (n= 13) after the acute event failed to uncover statistically significant differences. However, it is also possible that the relatively small sample size accounted for the absence of possible statistically significant differences.
As another potential shortcoming, the study included patients with and without early interventions such as thrombolytic therapy or direct angioplasty. The severity of the ischemic injury as well as the degree of reperfusion might therefore have varied between patients. Also, flow reductions with sustained glucose metabolic activity might have represented persistent ischemia in some patients but an adaptation to sustained flow reductions, defined as "hibernating myocardium," in others.27 Moreover, the absence of flow defects despite wall motion abnormalities in two patients with patent infarct arteries might have represented postischemic dysfunction or myocardial stunning.28 Last, myocardial stunning, hibernation, persistent ischemia, and necrosis might have coexisted in some patients. The present data therefore do not distinguish between different types of ischemic injury.
A third limitation is related to possible misalignments between segmental wall motion findings on echocardiography and estimates of functional processes derived from the PET images. Wall motion was examined in 18 segments on echocardiography and related to the 7 anatomic segments on the transaxial PET images as described previously in our laboratory. [5] [6] [7] [8] Despite the use of anatomic landmarks, for example, anterior and posterior papillary muscles or the insertion point of the right ventricular free wall into the septum, some degree of misalignment may have occurred. At the same time, it should be emphasized that the major thrust of this study was to characterize the relations between blood flow and glucose and oxidative metabolism rather than their relation to regional contractile function.
As another shortcoming, a uniform wall thickness of 1 cm was assumed for normal as well as PET mismatch and PET match segments in the present study. In patients with chronic coronary artery disease, diastolic wall thickness in myocardial regions with preserved '8F-deoxyglucose activity has been shown to be similar to that in normal myocardium.14 However, segments with more severe injury, for instance, those with matched perfusion-glucose metabolism defects, might have significantly reduced wall thicknesses.14 A reducrecovery coefficient about 15% lower, which in turn would have resulted in about 15% higher estimates of blood flow in such segments. Such underestimation of blood flows might have contributed to the data scatter in the low flow range. However, such underestimation would not explain the observed piecewise linear relation between blood flow and oxidative metabolism.
PET Mismatch and Match in Clinical Infarct Regions
In this study, 45% of the patients and 43% of the clinical infarct regions exhibited blood flow-metabolism mismatches. This incidence is similar to that reported previously in early postinfarction patients. 8 The findings suggest that contractile dysfunction was potentially reversible in such segments. Although long-term follow-up studies would be required to confirm this possibility, recently published observations in early postinfarction patients indicate that blood flow metabolism patterns do in fact predict with a relatively high degree of accuracy the long-term outcome in regional contractile function after successful revascularization.29
In four patients, blood flow-metabolism mismatches were detected within 3 days, whereas in six patients they were found 4 to 7 days after the acute infarction. Thus, the presence of mismatch was unrelated to the time between the infarction and the tomographic study and might be observed as long as 1 week after the acute event. The of a correlation between oxidative metabolism in match and in mismatch segments and the rate-pressure product. Although a recent study reported such a correlation for infarct segments, this correlation was only weak and did not discriminate between potentially viable and nonviable segments. 34 Blood flows were reduced more severely than oxidative metabolism in PET ischemic segments (35% vs 16%, P<.001). In contrast, both blood flow and oxidative metabolism were proportionally and more severely reduced in segments with blood flow metabolism matches (58% and 48%, P=NS). Both types of ischemic tissue injury existed for intermediate reductions of blood flow. One factor accounting for this overlap is the variable degree of transmural injury between patients, which may relate to the heterogeneity of the patient population in terms of thrombolysis or angioplasty or in terms of different timings of the PET study after the acute event. Inadequate corrections for partial volume effects cannot explain the observed overlap. More adequate corrections (lower recovery coefficients) would increase blood flows in the most severely injured segments, thereby enhancing the observed overlap. Regardless of the underlying mechanism, the variability of blood flow in perfusion-metabolism matches and mismatches suggests that flow measurements alone do not fully discriminate between these two types of tissue injury.
In contrast, less overlap was observed for normalized rates of oxidative metabolism. This observation might be consistent with the recently reported notion that oxidative metabolism as assessed with [11C]acetate may be a useful discriminator between complete and incomplete infarction. 29 Relation Between Blood Flow and Metabolism A previous study in patients with subacute and chronic myocardial infarctions has reported a linear relation between blood flow and oxidative metabolism. 35 Although this earlier study did not include segments with blood flows as low as in the present study, the observed piecewise relation was nevertheless unexpected. It (Fig 4) . The different steepnesses of these slopes indicate that decreases in blood flow are associated with smaller decrements in oxidative metabolism. Even if partial volume effects in normal regions with low flows were corrected inadequately, more accurate corrections and consequently higher estimates of flows would result in an even greater disparity in the slopes (as shown in Fig 4) . This would further accentuate the observed piecewise relation. Although accurate corrections for partial volume in clinical infarct regions are admittedly problematic, which in part may account for the data scatter in the low flow range, they are unlikely to account for the steep decline in oxidative metabolism. More appropriate corrections might have modified the slope of the steeper portion of the piecewise relation, thereby further accentuating the piecewise character of this relation.
To obtain the best fit for the relation between blood flow and oxidative metabolism, the optimum threshold between the low and the high flow range was determined by repeatedly fitting two regression lines simultaneously to the data by least-squares regression analysis.25 As a second step, the F test was used to test whether this relation was better described by a piecewise linear or linear fit.
To minimize the contribution of lateral spillover to the measured tissue tracer concentrations, small regions of interest were used. However, to rule out the possibility that segmental measurements of blood flow and oxidative metabolism were influenced by adjacent myocardial segments and were in fact not independent, their relation was also analyzed by use of the mean values for normal, PET mismatch, and match segments within each patient. Such analysis confirmed the piecewise linear relation between blood flow and oxidative metabolism. The piecewise linear fit was significantly better than a single linear fit (F=6.7>F=5.6; P<.01; best threshold, 0.57 mL * g`* min'). Thus, neither statistical limitations nor partial volume or spillover problems were likely to have accounted for the piecewise linear relation.
In the present study, flows of about 0.55 mL* g`1 * mink separated the flatter from the steeper portions of the piecewise relation. This value might represent a critical threshold. Together with decreases in contractile work, and thus in demand, increases in the oxygen extraction fraction may in fact compensate for a decrease in blood flow and thus oxygen supply. Such compensatory mechanisms may no longer be adequate when blood flow decreases further. In support of such a possibility of a critical threshold of blood flow are recent animal studies with nuclear magnetic resonance spectroscopy that demonstrated a preservation of high-energy phosphate levels for flow reductions by as much as 50% of normal. If blood flow declined below this level, high-energy phosphate concentrations decreased. 36 The observed piecewise relation is consistent with the data recently reported by Feigl et al. 37 These investigators incorporated previously reported animal experimental observations into a theoretical model that describes the interdependence between perfusion pressure, blood flow, and oxygen consumption. The model predicts a piecewise relation between oxygen consumption and blood flow that is nearly identical to that found in the present study. Oxygen consumption, according to this model, falls only gradually for flows down to about 0.5 mL. g`. min' but then declines more steeply with further decreases in flow. Increases in the extraction of oxygen in this model accounted for the initially only gradual decline in oxygen consumption. Such increases in the oxygen extraction fractions might reflect a compensatory mechanism to maintain adequate oxygenation in hypoperfused myocardium.
Increases in oxygen extractions might also account for the different relation of normalized blood flow to oxidative metabolism in PET mismatch and match segments (Fig 7) . The flatter slope of the regression line in PET mismatch than in PET match segments implies different oxygen extractions in these two tissue types. Values for oxygen extraction fractions in experimental animals range from 45% to 75% in normal myocardium, with increases to as much as 90% in hypoperfused myocardium.38,39 True values of oxygen extraction cannot be derived from the present data. However, the ratio between normalized oxidative metabolism and blood flow provides an index of oxygen extraction. Assuming an oxygen extraction fraction of 66% in normal myocardium as observed in patients with cardiac disease,40 a ratio of 1.25 in segments with mismatches, as calculated for flow reductions from 20% to 40%, would reflect a 25% increase of oxygen extraction to 82%. Such increases in oxygen extraction might maintain viability in hypoperfused myocardium and might offer an explanation for the recently reported high predictive accuracy of oxidative metabolism for the recovery of dysfunctional myocardium. 29 Unlike oxidative metabolism, rates of glucose utilization did not correlate with blood flow or the ratepressure product. This was because glucose utilization in normal myocardium varied considerably between patients. The observed variability of glucose metabolic rates between patients, despite standardization by oral glucose administration,41 may have been caused by (1) glucose intolerance in the majority of patients as evidenced by the high mean serum glucose levels in this population and (2) the effect of heparin on plasma free fatty acid levels and, consequently, on glucose utilization in four patients but also by other endocrine factors, for example, elevated plasma catecholamine levels. 42, 43 However, even demanding procedures such as the glucose-insulin clamp technique do not abolish the variability of glucose metabolic rates between patients. 41 In agreement with previous animal experimental studies, glucose metabolic rates were lower in normal myocardium of patients with blood flow metabolism mismatches than in those with matched defects. An inhibition of glucose uptake in normal myocardium of patients with high rates of glucose metabolism in mismatch segments might account for this finding. 44 Conversely, normalized glucose utilization in segments with matched defects correlated with normalized blood flow but, as expected, deviated from this relation in PET mismatch segments. This observation further suggests that normalized rather than absolute rates of glucose utilization are useful for identifying potentially reversible myocardial injury. The present data suggest that quantification of rates of glucose utilization is of limited use for assessing potentially reversible myocardial contractile dysfunction in patients with a recent myocardial infarction. The value of relative glucose metabolic studies for the prediction of reversible tissue dysfunction remains unclear. Serial assessment of regional wall motion will be required to determine the predictive value of preserved glucose utilization for functional recovery of recently injured myocardium.
Summary and Clinical Implications
This study identified two distinct patterns of blood flow and metabolism in clinical infarct regions. The relatively high incidence of blood flow metabolism mismatches suggests that ischemia can persist in a substantial fraction of clinically infarcted myocardium, even as long as 1 week after the acute event. Such regions cannot be identified solely by flow criteria, since modest to severe flow reductions are associated with both potentially salvageable and probably irreversibly injured myocardium. Mild to moderate flow reductions were associated with disproportionately smaller decreases in oxidative metabolism, probably because of an increase in the oxygen extraction. The latter may represent a compensatory mechanism for maintaining an adequate balance of high-energy phosphate. At the same time, it may also account for the usefulness of [11C]acetate as a marker of viability or reversible tissue dysfunction. 29 The steep decline in oxidative metabolism with further flow decreases may in fact denote a critical threshold in myocardial ischemia that might separate reversible from irreversible tissue injury.
